KEAP1 and lung disorder: Studies have found that Peimisine can inhibit oxidative stress, DNA damage, apoptosis and autophagy dysregulation through the NRF2/KEAP1 and JNK/MAPK-dependent pathways, thereby slowing down the pathological progression of lung diseases (Liu et al., 2024).